Dashboard
Manage Tickers

ADMS


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benzingas-top-ratings-upgrades-downgrades-for-november-17-2021
Benzinga's Top Ratings Upgrades, Downgrade...
11/17/2021 15:03:23

 

northland-capital-markets-downgrades-adamas-pharmaceuticals-to-market-perform-announces-85-price-target
Northland Capital Markets Downgrades Adama...
11/17/2021 12:41:45

Northland Capital Markets analyst Carl Byrnes downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perf...

adamis-pharmaceuticals-shares-move-higher-traders-circulate-event-page-for-virginiabio-bz-note-co-to-present-wednesday-nov-17
Adamis Pharmaceuticals Shares Move Higher;...
11/16/2021 19:33:25

https://www.vabio.org/event/use-of-tempol-as-an-antiviral-therapeutic-against-covid-19/

adamas-pharmaceuticals-shares-move-higher-magnetar-financial-reports-in-13d-filing-a-685-stake-in-co
Adamas Pharmaceuticals Shares Move Higher;...
10/19/2021 20:29:48

-SEC Filing

benzingas-top-ratings-upgrades-downgrades-for-october-12-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/12/2021 14:48:07

Upgrades

jmp-securities-downgrades-adamas-pharmaceuticals-to-market-perform
JMP Securities Downgrades Adamas Pharmaceu...
10/12/2021 10:52:42

JMP Securities analyst Jason Butler downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Market Outperform to Market Perform.

piper-sandler-downgrades-adamas-pharmaceuticals-to-neutral-raises-price-target-to-8
Piper Sandler Downgrades Adamas Pharmaceut...
10/12/2021 10:48:41

Piper Sandler analyst David Amsellem downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Overweight to Neutral and raises t...

hc-wainwright--co-downgrades-adamas-pharmaceuticals-to-neutral-lowers-price-target-to-91
HC Wainwright & Co. Downgrades Adamas Phar...
10/12/2021 10:40:13

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Buy to Neutral and l...

46-biggest-movers-from-yesterday
46 Biggest Movers From Yesterday
10/12/2021 09:01:23

Gainers

Core News & Articles
Mid-Afternoon Market Update: Dow Tumbles O...
10/11/2021 19:17:03

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
10/11/2021 17:21:26

 

Core News & Articles
Mid-Day Market Update: Crude Oil Surges Ov...
10/11/2021 16:13:16

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also ...

Core News & Articles
28 Stocks Moving In Monday's Mid-Day Session
10/11/2021 16:04:57

Gainers

william-blair-downgrades-adamas-pharmaceuticals-to-market-perform
William Blair Downgrades Adamas Pharmaceut...
10/11/2021 15:44:16

William Blair analyst Tim Lugo downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perform.

supernus-bolsters-parkinsons-portfolio-with-450m-adamas-buyout-highlights
Supernus Bolsters Parkinson's Portfolio Wi...
10/11/2021 12:53:24

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
10/11/2021 12:12:37

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market sessio...

Core News & Articles
Supernus Pharmaceuticals To Acquire Adamas...
10/11/2021 10:31:59

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS), today announced a definitive agree...

adamas-announces-gocovri-presentations-at-upcoming-international-parkinson-and-movement-disorder-societys-congress-sept-17-22
Adamas Announces GOCOVRI Presentations At ...
09/16/2021 13:19:54

looking-into-adamas-pharmaceuticalss-return-on-capital-employed
Looking Into Adamas Pharmaceuticals's Retu...
09/10/2021 15:53:17

According to data from Benzinga Pro, during Q2, Adamas Pharmaceuticals's (NASDAQ:ADMS) reported sales totaled $21.97 millio...

adamas-pharmaceuticals-q2-eps-027-beats-029-estimate-sales-2200m-beat-2195m-estimate
Adamas Pharmaceuticals Q2 EPS $(0.27) Beat...
08/09/2021 20:14:16

Adamas Pharmaceuticals (NASDAQ:ADMS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate o...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION